Indivior PLC has successfully completed its transition to a primary listing in the U.S., as reported on June 27, 2024. This is a significant event reflecting the company's strategic move.
AI Assistant
INDIVIOR PHARMACEUTICALS INC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.